Filter by identifiers:
Displaying metabolites 2751 - 2775 of 3755 in total
Metabolite ID Name
CAS Number
IUPAC NameSMPDB PathwaysWeight
Formula
Structure
ECMDB21000D-Urobilinogen

17208-65-0
3-(2-{[3-(2-carboxyethyl)-5-[(4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-2-yl]methyl}-5-[(3-ethyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-3-yl)propanoic acid
590.7098

C33H42N4O6
Thumb
ECMDB20622XDP

[({[(2R,3S,4R,5R)-5-(2,6-dihydroxy-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid
Collection of Reactions without pathways PW001891
444.1853

C10H14N4O12P2
Thumb
ECMDB20621UDP-N-Acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminoheptanedioate-D-alanine

1-[(2R,3R,4S,5R)-5-{[({[(2R,3R,4R,5S,6R)-4-[(1R)-1-{[(1S)-1-{[(1R)-3-{[(1S,5R)-5-amino-5-carboxy-1-{[(1R)-1-carboxyethyl]-C-hydroxycarbonimidoyl}pentyl]carboximidato}-1-carboxypropyl]-C-hydroxycarbonimidoyl}ethyl]-C-hydroxycarbonimidoyl}ethoxy]-5-hydroxy-6-(hydroxymethyl)-3-[(1-oxidoethylidene)amino]oxan-2-yl phosphonato]oxy}phosphinato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxo-2,5-dihydro-1λ⁵-pyrimidine-1,5-bis(ylium)
1118.8362

C38H56N8O27P2
Thumb
ECMDB20620Ubiquinone-6

1065-31-2
2-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
TCA cycle (ubiquinol-6) PW001006
590.8754

C39H58O4
Thumb
ECMDB20619Ubiquinol-10

5677-55-4
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-diol
TCA cycle (ubiquinol-10) PW001010
865.3594

C59H92O4
Thumb
ECMDB20613dTDP-4-Acetamido-4,6-dideoxy-D-galactose

{[(3R,4S,6R)-5-acetamido-3,4-dihydroxy-6-methyloxan-2-yl]oxy}({[hydroxy({[3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy})phosphinic acid
Secondary Metabolites: enterobacterial common antigen biosynthesis 3 PW002046
589.3815

C18H29N3O15P2
Thumb
ECMDB20612dTDP-D-Fucosamine

[({[(2R,3R,4S,5R,6R)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]({[3-hydroxy-5-(4-hydroxy-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid
Secondary Metabolites: enterobacterial common antigen biosynthesis 3 PW002046
547.3448

C16H27N3O14P2
Thumb
ECMDB20611trans-Delta2, cis-delta4-decadienoyl-CoA

4-({[({[(2S,3S,4R,5S)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-N-(2-{[2-(deca-2,4-dienoylsulfanyl)ethyl]-C-hydroxycarbonimidoyl}ethyl)-2-hydroxy-3,3-dimethylbutanimidic acid
917.75

C31H50N7O17P3S
Thumb
ECMDB20610Sn-Glycerol-1-phosphate

5746-57-6
[(2S)-2,3-dihydroxypropoxy]phosphonic acid
172.0737

C3H9O6P
Thumb
ECMDB20608L-Seryl-AMP

52435-67-3
{[(2S)-2-amino-3-hydroxypropanoyl]oxy}({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid
434.2985

C13H19N6O9P
Thumb
ECMDB20604S-Carboxymethyl-D-cysteine

2-[(2-amino-2-carboxyethyl)sulfanyl]acetate
178.186

C5H8NO4S
Thumb
ECMDB20601Cyclic pyranopterin monophosphate

(4aR,5aR,11aR,12aS)-2,10,12,12-tetrahydroxy-8-imino-4,4a,5a,6,7,8,11,11a,12,12a-decahydro-2H-1,3,5-trioxa-6,7,9,11-tetraaza-2lambda5-phosphatetracen-2-one
Folate biosynthesis PW000908
GTP degradation PW001888
363.2206

C10H14N5O8P
Thumb
ECMDB20599Phenylhydantoin

89-24-7
4-phenyl-4H-imidazole-2,5-diol
Collection of Reactions without pathways PW001891
176.172

C9H8N2O2
Thumb
ECMDB20598Phenylglyoxal

1074-12-0
2-oxo-2-phenylacetaldehyde
134.132

C8H6O2
Thumb
ECMDB20594NMNH

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1,4-dihydropyridine-3-carboximidic acid
336.235

C11H17N2O8P
Thumb
ECMDB20591N3-Methylcytosine

6-amino-1-methyl-2-oxo-2,3-dihydropyrimidin-1-ium
126.1365

C5H8N3O
Thumb
ECMDB20590N1-Methyladenine

5142-22-3
1-methyl-6,9-dihydro-1H-purin-6-imine
149.1533

C6H7N5
Thumb
ECMDB20581L-Glyceraldehyde 3-phosphate

{[(2S)-2-hydroxy-3-oxopropoxy]dioxo-λ⁵-phosphanuidyl}oxidanyl
168.042

C3H5O6P
Thumb
ECMDB20580L-Glyceraldehyde

497-09-6
(2S)-2,3-dihydroxypropanal
90.0779

C3H6O3
Thumb
ECMDB20579Linear dimeric GMP

9-[(2R,3R,4S,5R)-4-[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-imino-6-oxido-3,9-dihydro-2H-purin-9-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-5-[(hydrogen phosphonatooxy)methyl]-3-hydroxyoxolan-2-yl]-2-imino-3,9-dihydro-2H-purin-6-olate
705.4021

C20H23N10O15P2
Thumb
ECMDB20578L-Carnitinyl-CoA

[4-({2-[(3-{[4-({[({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulfanyl)-2-hydroxy-4-oxobutyl]trimethylazanium
911.726

C28H50N8O18P3S
Thumb
ECMDB20576L-Ara4N-modified KDO2-Lipid A

2-{[3-({[(5-amino-3,4-dihydroxyoxan-2-yl)oxy](hydroxy)phosphoryl}oxy)-6-{[6-({[(5-amino-3,4-dihydroxyoxan-2-yl)oxy](hydroxy)phosphoryl}oxy)-5-[(1,3-dihydroxytetradecylidene)amino]-3-hydroxy-4-[(3-hydroxytetradecanoyl)oxy]oxan-2-yl]methoxy}-5-{[3-(dodecanoyloxy)-1-hydroxytetradecylidene]amino}-4-{[3-(tetradecanoyloxy)tetradecanoyl]oxy}oxan-2-yl]methoxy}-4-{[2-carboxy-6-(1,2-dihydroxyethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-(1,2-dihydroxyethyl)-5-hydroxyoxane-2-carboxylic acid
polymyxin resistance PW002052
2500.9781

C120H220N4O45P2
Thumb
ECMDB20575L-Ala-gamma-D-Glu-Dap

4-[(2-amino-1-hydroxypropylidene)amino]-4-[(6-imino-1,6-dihydropyridin-2-yl)-C-hydroxycarbonimidoyl]butanoic acid
309.3211

C13H19N5O4
Thumb
ECMDB20574L-Ala-gamma-D-Glu

(4R)-4-{[(2S)-2-amino-1-hydroxypropylidene]amino}-4-carboxybutanoate
217.1992

C8H13N2O5
Thumb
ECMDB20573L-Ala-D-Glu-meso-A2pm

(2R,6S)-2-amino-6-{[(4R)-4-{[(2S)-2-amino-1-hydroxypropylidene]amino}-4-carboxy-1-hydroxybutylidene]amino}heptanedioic acid
390.3889

C15H26N4O8
Thumb
Displaying metabolites 2751 - 2775 of 3755 in total